Retlira (Retatrutide) 30mg Pen - UPA

RETLIRA 30MG PEN
Advanced Weight Management & Metabolic Reset
 

 What Is RETLIRA?
RET LIRA is a powerful triple-action peptide therapy containing 30mg of
Retratrutide, a new-generation weight loss compound targeting:
 ✅ GLP-1 receptors – reduces hunger & stabilizes blood sugar
 ✅ GIP receptors – improves insulin sensitivity
 ✅ Glucagon receptors – boosts fat burning & metabolism
RET LIRA mimics three key metabolic hormones in one weekly injection,
outperforming older GLP-1 options like Semaglutide and Tirzepatide.

✅ Why Choose RET LIRA (Retratrutide) Pen?

 High-strength Retratrutide – clinically backed for fat loss & glucose control
 Convenient pre-filled 30mg pen
 Ideal for those who’ve plateaued on Semaglutide or Tirzepatide
 Supports long-term appetite regulation, visceral fat loss, and insulin
improvement
 Used in cutting-edge obesity protocols
Triple action. One injection. Total transformation.

Active Ingredient Retratrutide 30mg per pen
Total Volume 3ml (10mg/ml)
Dosing Adjustable dial, 2.5mg–15mg per week
Injection Type Subcutaneous (abdomen, thigh, upper arm)
Use Frequency Once per week
Storage Refrigerate unopened (2–8°C). Use within 30 days once opened.

Format Prefilled, dial-dose pen (multi-week use)
➡️ One pen lasts 2 to 12 weeks, depending on dosage. Use once weekly on the same day each week.

DOSAGE CALCULATOR – RETRATRUTIDE 
Wee Suggested Volume to Dial (ml @ Effective Dose 10mg/ml)
1–2 2.5mg 0.25ml Intro phase – reduce nausea

3–4 5.0mg 0.5ml Appetite control begins
5–6 7.5mg 0.75ml Fat burn stage
7–8 10.0mg 1.0ml Full therapeutic level
9+ 12.5–15.0mg 1.25–1.5ml Maximum dose (if
tolerated)
 

Each 0.1ml = 1mg based on 10mg/ml concentration.